Healthcare >> Analyst Interviews >> November 24, 2003
DR. KENNETH GOLDMAN is a Vice President and Equity Analyst with Lehman
Brothers. His research coverage is focused on the life science enabling
tools sector. Prior to his tenure at Lehman Brothers, Dr. Goldman was
the Director of the Cornea Transplant Service and an Associate Clinical
Professor of Ophthalmology at the Albert Einstein School of Medicine. He
has performed basic research in corneal physiology, invented patented
surgical instruments and directed the launch and development of a multi-
site eye-care system for a New York managed care organization. Dr.
Goldman is a Phi Beta Kappa graduate of Union College, Schenectady, New
York. He received his MD degree from the New York University School of
Medicine and his MBA with distinction from Columbia University School of
Business. Profile
Dr. Goldman: I cover the life science enabling tool space. These are the
companies that make specialized analytical instruments
